RETINOPATHY OF PREMATURITY (ROP)
Clinical trials for RETINOPATHY OF PREMATURITY (ROP) explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY (ROP) trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY (ROP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to save premature babies' eyesight
Disease control Recruiting nowThis early-stage study tests a new medicine called FLQ-101 in 18 premature babies born at 26-27 weeks who are at high risk for retinopathy of prematurity (ROP), an eye disease that can cause blindness. The main goal is to check if the drug is safe and how it works in the body. Re…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: PHASE1 • Sponsor: FELIQS INC. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Breakthrough trial aims to prevent lung damage in tiniest newborns
Prevention Recruiting nowThis study tests an investigational drug called OHB-607 to see if it can prevent bronchopulmonary dysplasia (BPD), a serious chronic lung disease, in extremely premature infants. About 338 babies will be randomly assigned to receive either the drug or standard care. The goal is t…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: PHASE2 • Sponsor: OHB Neonatology Ltd. • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC